chr10-11463309-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014688.5(USP6NL):c.1619A>T(p.Glu540Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000867 in 1,613,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014688.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
USP6NL | NM_014688.5 | c.1619A>T | p.Glu540Val | missense_variant | 15/15 | ENST00000609104.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
USP6NL | ENST00000609104.6 | c.1619A>T | p.Glu540Val | missense_variant | 15/15 | 1 | NM_014688.5 | P1 | |
USP6NL | ENST00000379237.6 | c.1688A>T | p.Glu563Val | missense_variant | 14/14 | 5 | |||
USP6NL | ENST00000277575.5 | c.1670A>T | p.Glu557Val | missense_variant | 14/14 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249092Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135164
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461630Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 6AN XY: 727102
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 07, 2023 | The c.1670A>T (p.E557V) alteration is located in exon 14 (coding exon 14) of the USP6NL gene. This alteration results from a A to T substitution at nucleotide position 1670, causing the glutamic acid (E) at amino acid position 557 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at